[HTML][HTML] Type 2 inflammation contributes to skin barrier dysfunction in atopic dermatitis

LA Beck, MJ Cork, M Amagai, A De Benedetto… - JID Innovations, 2022 - Elsevier
Skin barrier dysfunction, a defining feature of atopic dermatitis (AD), arises from multiple
interacting systems. In AD, skin inflammation is caused by host–environment interactions …

pH in nature, humans and skin

E Proksch - The Journal of dermatology, 2018 - Wiley Online Library
The pH plays an important physiological role in nature and humans. pH varies from 1 to 8 in
human organs with tight regulation in blood and epithelia of barrier organs. The …

Atopic dermatitis: Role of the skin barrier, environment, microbiome, and therapeutic agents

T Luger, M Amagai, B Dreno, MA Dagnelie… - Journal of …, 2021 - Elsevier
Atopic dermatitis (AD) is a chronic, inflammatory skin disorder characterized by eczematous
and pruritic skin lesions. In recent decades, the prevalence of AD has increased worldwide …

Revisiting the roles of filaggrin in atopic dermatitis

V Moosbrugger-Martinz, C Leprince… - International Journal of …, 2022 - mdpi.com
The discovery in 2006 that loss-of-function mutations in the filaggrin gene (FLG) cause
ichthyosis vulgaris and can predispose to atopic dermatitis (AD) galvanized the dermatology …

[HTML][HTML] Application of moisturizer to neonates prevents development of atopic dermatitis

K Horimukai, K Morita, M Narita, M Kondo… - Journal of Allergy and …, 2014 - Elsevier
Background Recent studies have suggested that epidermal barrier dysfunction contributes
to the development of atopic dermatitis (AD) and other allergic diseases. Objective We …

[HTML][HTML] Dysbiosis and Staphylococcus aureus colonization drives inflammation in atopic dermatitis

T Kobayashi, M Glatz, K Horiuchi, H Kawasaki… - Immunity, 2015 - cell.com
Staphylococcus aureus skin colonization is universal in atopic dermatitis and common in
cancer patients treated with epidermal growth factor receptor inhibitors. However, the causal …

Atopic dermatitis: the skin barrier and beyond

T Tsakok, R Woolf, CH Smith… - British Journal of …, 2019 - academic.oup.com
Background Atopic dermatitis is the most common chronic inflammatory skin disorder,
affecting up to 20% of children and 10% of adults in industrialized countries. This highly …

Skin barriers in dermal drug delivery: which barriers have to be overcome and how can we measure them?

C Gorzelanny, C Mess, SW Schneider, V Huck… - Pharmaceutics, 2020 - mdpi.com
Although, drugs are required in the various skin compartments such as viable epidermis,
dermis, or hair follicles, to efficiently treat skin diseases, drug delivery into and across the …

Protease-activated receptors in health and disease

CJ Peach, LE Edgington-Mitchell… - Physiological …, 2023 - journals.physiology.org
Proteases are signaling molecules that specifically control cellular functions by cleaving
protease-activated receptors (PARs). The four known PARs are members of the large family …

Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches

DYM Leung, E Guttman-Yassky - Journal of Allergy and Clinical …, 2014 - Elsevier
Atopic dermatitis (AD) is the most common chronic inflammatory skin disease. It often
precedes the development of food allergy and asthma. Recent insights into AD reveal …